West Pharmaceutical Services, Inc.
DE ˙ DB ˙ GB00BLGXWY71
269,50 € ↑3,00 (1,13%)
2026-06-04
AKTIENPREIS
SecurityDE:WPS / West Pharmaceutical Services, Inc.
InstitutionLido Advisors, LLC
Latest Disclosed Ownership4,094 shares
Latest Disclosed Value $ 1,026,334
Lido Advisors, LLC reports 187.70% increase in ownership of WPS / West Pharmaceutical Services, Inc.

On May 13, 2026 - Lido Advisors, LLC filed a 13F-HR form disclosing ownership of 4,094 shares of West Pharmaceutical Services, Inc. (DE:WPS) valued at $874,069 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 1,423 shares of West Pharmaceutical Services, Inc.. This represents a change in shares of 187.70% during the quarter. The current value of the position is $1,103,333 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 4,094 2,671 187.70 1,026 172.15 0.0031
2026-02-10 2025-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,423 26 1.86 378 3.01 0.0011
2025-11-14 2025-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,397 85 6.48 367 27.53 0.0011
2025-08-13 2025-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,312 -1,532 -53.87 287 -54.87 0.0011
2025-05-15 2025-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 2,844 87 3.16 637 -29.57 0.0029
2025-02-14 2024-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 2,757 -38 -1.36 903 7.63 0.0041
2024-11-14 2024-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 2,795 1,803 181.75 839 156.57 0.0042
2024-08-15 2024-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 992 -8 -0.80 327 -17.22 0.0018
2024-05-15 2024-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,000 40 4.17 396 17.21 0.0023
2024-02-14 2023-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 960 172 21.83 338 14.24 0.0023
2023-11-14 2023-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 788 106 15.54 296 13.46 0.0022
2023-08-09 2023-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 682 682 261 0.0019
2023-02-14 2022-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 0 -1,059 -100.00 0 -100.00
2022-11-14 2022-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,059 -1,526 -59.03 260 -66.71 0.0033
2022-08-15 2022-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 2,585 13 0.51 781 -26.04 0.0104
2022-05-17 2022-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 2,572 62 2.47 1,056 -10.28 0.0118
2022-02-15 2021-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 2,510 409 19.47 1,177 32.10 0.0128
2022-02-15 2021-09-30 13F/A-1 WEST PHARMACEUTICAL SVSC COM 955306105 2,101 -159 -7.04 891 9.73 0.0124
2021-11-12 2021-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 66,977 64,717 892 0.0116
2021-08-12 2021-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 2,260 -76 -3.25 812 23.40 0.0113
2021-05-13 2021-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 2,336 17 0.73 658 0.30 0.0192
2021-02-08 2020-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 2,319 -474 -16.97 656 -14.58 0.0221
2020-11-12 2020-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 2,793 1,421 103.57 768 146.15 0.0329
2020-08-12 2020-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,372 -152 -9.97 312 34.48 0.0152
2020-05-13 2020-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,524 91 6.35 232 7.91 0.0150
2020-02-07 2019-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,433 1,433 215 0.0125
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.